Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1999

Conditions

LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

DRUG

mycophenolate mofetil

DRUG

tacrolimus

PROCEDURE

allogeneic bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00006042 - Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter